Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

BACKGROUND: Clinicopathological studies suggest that Alzheimer's disease (AD) pathology begins ∼10–15 years before the resulting cognitive impairment draws medical attention. Biomarkers that can detect AD pathology in its early stages and predict dementia onset would, therefore, be invaluable f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Craig-Schapiro, Rebecca, Kuhn, Max, Xiong, Chengjie, Pickering, Eve H., Liu, Jingxia, Misko, Thomas P., Perrin, Richard J., Bales, Kelly R., Soares, Holly, Fagan, Anne M., Holtzman, David M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2011
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079734/
https://ncbi.nlm.nih.gov/pubmed/21526197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018850
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia